Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
AGN Allergan plc daily Stock Chart
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-9.35 Insider Own0.20% Shs Outstand393.64M Perf Week-4.57%
Market Cap108.19B Forward P/E16.72 EPS next Y16.44 Insider Trans- Shs Float392.70M Perf Month-6.39%
Income-2623.60M PEG- EPS next Q4.46 Inst Own88.50% Short Float1.55% Perf Quarter-13.67%
Sales17.73B P/S6.10 EPS this Y-40.80% Inst Trans0.37% Short Ratio1.96 Perf Half Y-6.54%
Book/sh171.01 P/B1.61 EPS next Y-7.97% ROA-2.70% Target Price362.65 Perf Year13.44%
Cash/sh3.88 P/C70.88 EPS next 5Y12.25% ROE-5.50% 52W Range208.64 - 340.34 Perf YTD6.77%
Dividend0.20 P/FCF39.76 EPS past 5Y-42.20% ROI-2.70% 52W High-19.25% Beta0.62
Dividend %0.07% Quick Ratio1.00 Sales past 5Y36.10% Gross Margin57.40% 52W Low31.73% ATR13.02
Employees21600 Current Ratio1.40 Sales Q/Q8.10% Oper. Margin-10.10% RSI (14)43.80 Volatility5.01% 4.81%
OptionableYes Debt/Eq0.64 EPS Q/Q-229.00% Profit Margin-14.80% Rel Volume1.22 Prev Close276.16
ShortableYes LT Debt/Eq0.62 EarningsNov 04 BMO Payout- Avg Volume3.11M Price274.84
Recom1.70 SMA20-3.06% SMA50-8.45% SMA200-6.92% Volume3,793,425 Change-0.48%
Oct-09-15Initiated Mizuho Buy
Sep-29-15Initiated Nomura Buy
Aug-07-15Reiterated RBC Capital Mkts Outperform $361 → $375
Aug-07-15Reiterated Deutsche Bank Buy $346 → $350
Aug-03-15Resumed JP Morgan Overweight $375 → $400
Jul-28-15Reiterated Leerink Partners Outperform $354 → $388
Jul-28-15Reiterated Canaccord Genuity Buy $352 → $396
Jul-17-15Downgrade RBC Capital Mkts Top Pick → Outperform $361
Oct-09-15 04:23PM  Tesla Downgraded On Model X; Jazz, Allergan Get Buys at Investor's Business Daily
03:44PM  World Mental Health Day: De-Stress with 4 Stocks
11:25AM  How To Invest During Biotech's Latest Crisis
08:23AM  Amgen Was Clobbered in September -- Here's Why at Motley Fool
07:01AM  FDA Accepts Supplemental New Drug Application (sNDA) for DALVANCE® (dalbavancin) PR Newswire
Oct-08-15 04:42PM  Drug costs need to be US priority: CEO
04:15PM  Allergan To Host R&D Day And Third Quarter 2015 Conference Call And Webcast November 4 PR Newswire
10:15AM  Hot Political Rhetoric Hammers Specialty Pharmaceuticals: 3 to Buy Now at 24/7 Wall St.
07:01AM  Allergan Anti-Infective Portfolio Highlighted in 13 Abstracts at IDWeek 2015 PR Newswire
Oct-07-15 06:13PM  Your first look for Thursday, October 8 at CNBC
05:58PM  Final Trade: AGN, KRE, ANTM, & GPRO
01:16PM  Videocast: VIX call buyers return
11:21AM  How one bull is playing Allergan
Oct-06-15 05:00PM  Acorda Soars, Settles Ampyra Patent Dispute with Allergan
02:09PM  Biotech slammed again, now what?
12:38PM  What's Wrong With Health Care? at
12:03PM  Has Valeant Fallen Too Far? at
07:01AM  Allergan and Medicines360 Announces LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg IUS Presented in 3 Abstracts at FIGO 2015 PR Newswire
Oct-05-15 04:15PM  3 Stocks with Strong Competitive Positions at Motley Fool
03:06PM  Don't Worry Spec. Pharma Investors, Drug Pricing Legislation Probably Won't Affect You
03:03PM  Acorda, Allergan Make Surprise Deal On Ampyra Patent at Investor's Business Daily
Oct-02-15 10:00AM  Pharma Deals in Latin America Continue, Teva to Buy Rimsa
08:30AM  Allergan and Humana Announce Research Partnership to Improve Health Outcomes PR Newswire
07:01AM  KYBELLA® Injection Wins Allure Magazine "Best of Beauty" Award PR Newswire
Oct-01-15 04:29PM  ALLERGAN PLC Files SEC form 8-K, Other Events
09:10AM  Allergan Successfully Completes Kythera Acquisition; Adds Game-Changing KYBELLA Treatment for Double-Chin PR Newswire
08:57AM  Teva to Acquire Mexico Drug Maker Rimsa for $2.3 Billion at The Wall Street Journal
07:55AM  Analysts' Actions -- Allergan, Microsoft, Universal Health, World Wrestling Entertainment and More
07:01AM  U.S. FDA Approves JUVEDERM® ULTRA XC for Use in Lips PR Newswire
Sep-30-15 04:52PM  Allergan (AGN) Stock Spiked on Strong Revenue Projection at TheStreet +7.82%
04:42PM  Wednesday's After-Hours Movers: PBF Energy, BioMarin Pharmaceutical And More
04:12PM  ALLERGAN PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
12:34PM  3 Big Drugs Likely To Hit The Market Soon at Investor's Business Daily
11:01AM  Five Foreign Stocks To Buy Now at Insider Monkey
08:04AM  Investment-Grade Bond Yields Rise after Fed Comment on Rate Hike
06:36AM  If you liked health-care stocks before, youll love them now at MarketWatch
06:36AM  If you liked health-care stocks before, youll love them now
Sep-29-15 08:27PM  Three Pharmas Highlight Contrasting Approaches To Product Innovation at Forbes
04:36PM  Valeant's Big Winners -- Pershing Square, ValueAct --- Take a Big Hit at The Wall Street Journal
04:30PM  Allergan (AGN) Projects Revenues to Surpass $8B in 2H15
03:27PM  5 Specialty Pharma Stocks Nomura Is Picking To Weather The Storm
01:37PM  2 Pharma Stocks To Hide In While Drug Pricing Fears Play Out
01:30PM  We'll end the year significantly lower: Pro
11:39AM  Allergan Guidance Update Gets Mixed Reception at Investor's Business Daily
10:29AM  Why Cowen Thinks Allergan Has Massive Upside To $400
09:29AM  Stocks to Watch: Allergan, Yahoo, Sysco, IHS at The Wall Street Journal
08:32AM  Morning Movers: Look At All the Pharma Upgrades! at
Sep-28-15 06:58PM  U.S. Mergers In 2015 Reach Record Pace -8.66%
05:38PM  Allergan Sees 10% Rise in Branded Revenue at The Wall Street Journal
05:33PM  What to buy on a biotech buying spree
05:06PM  Allergan forecasts second-half revenue above $8 billion
05:02PM  Allergan forecasts 2nd-half revenue above $8 bln
04:15PM  Allergan Announces Updated Second-Half 2015 Continuing Operations Financial Forecast PR Newswire
01:23PM  Valeant got spanked
Sep-25-15 08:15PM  Stock Market Today - 09/25/15
12:02PM  Corporate Bond Issuance Tops $1 Trillion in U.S. at The Wall Street Journal
11:45AM  Corporate bond issuance tops $1 trillion in U.S. at MarketWatch
10:00AM  Shire's (SHPG) Vyvanse U.S. Patent Validated, Expiry in 2023
08:00AM  Allergan Launches Generic Version of INVEGA® (paliperidone) PR Newswire
Sep-24-15 08:06PM  Stock Market Today - 09/24/15
04:30PM  Amgen, Allergan's Biosimilar of Avastin Tops Phase III Study
03:00PM  U.S. appeals court upholds Shire's patents on hyperactivity drug
11:34AM  Activist Hedge Fund Manager Dan Loeb Decreases Position in Leading Biotech Company
10:39AM  Can Valeant Recover From Clinton Price Gouging Tweet?
08:03AM  Amgen Gets a Step Closer to a Multibillion-Dollar Market at Motley Fool
Sep-23-15 05:44PM  Amgen, Allergan Biosimilar Avastin Hits In Trial at Investor's Business Daily
05:15PM  Amgen, Allergan say their Avastin biosimilar showing positive results at
01:24PM  Biotech on its heels
12:37PM  Facebook, Starbucks Boost Big-Cap Heft With Big Buys at Investor's Business Daily
10:43AM  Amgen, Allergan say Avastin copycat succeeds in lung cancer study Reuters
09:56AM  Amgen, Allergan Biosimilar Lung-Cancer Therapy Shows Positive Results at The Wall Street Journal
09:00AM  Amgen And Allergan Announce Positive Top-line Results From Phase 3 Study of Biosimilar Candidate ABP 215 PR Newswire
Sep-22-15 06:37PM  Biotech stocks fall further as Hillary Clinton unveils drug policy at Financial Times
06:00AM  Jim Cramer's Top Takeaways: Allergan, Randgold, La Quinta at TheStreet
04:40AM  Richter's New Drug to Take Years to Offset Russia Woes, CEO Says at Bloomberg
Sep-21-15 08:21PM  Jim Cramer's 'Mad Money' Recap: Why Is This Market So Irrational? at TheStreet
07:20PM  Cramer Remix: The right time to raise rates at CNBC
06:24PM  Allergan CEO fires back on Hillary Clinton tweet at CNBC
06:15PM  Allergan CEO: Turing price spike 'one egregious situation...
02:52PM  Major Indexes Still Mixed; Red Hat Up Ahead Of Earnings at Investor's Business Daily
12:00PM  Allergan Supports World Alzheimer's Disease Day by Giving Back PR Newswire
10:40AM  New Campaign Thanks Caregivers of People with Alzheimer's Disease PR Newswire
08:00AM  Allergan Confirms Generic Rytary® Patent Challenge PR Newswire
Sep-20-15 05:25AM  Billionaires Cant Live Without These 10 Stocks at Insider Monkey
Sep-19-15 10:20AM  Billionaires See A Healthy Future For These Healthcare Stocks at Insider Monkey
Sep-18-15 04:50PM  Allergan/Gedeon's Vraylar Gets FDA Nod for Mental Disorders
09:55AM  Why Did These 4 S&P 500 Companies Hire Outsiders as Their Chief Executives? at TheStreet
04:29AM  CEE MARKETS 1-Forint outperforms on positive S&P review, FX flat on Fed Reuters
Sep-17-15 03:37PM  Allergan gets FDA nod for new antipsychotic Reuters
02:30PM  Allergan and Gedeon Richter Plc. Receive FDA Approval of VRAYLAR (cariprazine) for Treatment of Manic or Mixed Episodes of Bipolar I Disorder and Schizophrenia in Adults PR Newswire
09:47AM  Shareholders should reject Mylan offer: Perrigo CEO
08:03AM  Perrigo urges shareholders to reject Mylan takeover offer
Sep-16-15 12:31PM  This Small Biotech Is Roaring Higher
08:05AM  Allergan Partners with U.S. Women's Health Alliance Increasing Access to LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg PR Newswire
08:02AM  Allergan Anti-Infective Portfolio Highlighted in 24 Abstracts at ICAAC 2015 PR Newswire
Sep-15-15 11:16AM  7 Health Care Stocks John Paulson Is Betting On in 2015 at TheStreet
10:32AM  JPMorgan Picks 7 Pharmaceutical Stocks to Buy (or Hold) in Wake of Interest Rates Hike at TheStreet
08:29AM  Mylan opens $27.14 billion hostile bid for Perrigo
Sep-14-15 03:25PM  Drug deals & a rate hike
03:14PM  Dealpolitik: Mylan Bid Shines Spotlight on Fundamental M&A Governance Question at The Wall Street Journal
Allergan plc develops, manufactures, and distributes generic, branded, biosimilar, and over-the-counter (OTC) pharmaceutical products. It operates in three segments: North American Brands, North American Generics and International, and Anda Distribution. The North American Brands segment provides patented and off-patent trademarked pharmaceutical products primarily under the Dalvance, Bystolic, Canasa, Carafate, Daliresp, Fetzima, Linzess, Namenda, Namenda XR, Saphris, Teflaro, Viibryd, Actonel, Asacol HD, Atelvia, Delzicol, Doryx, Estrace Cream, Enablex, Lo Loestrin Fe, and Minastrin 24 Fe brands. The North American Generics and International segment develops, manufactures, and sells generic, branded generic, and OTC pharmaceutical products. The Anda Distribution segment distributes generic and brand pharmaceutical products primarily to independent pharmacies, pharmacy chains and buying groups, and physician's offices. The company also develops and out-licenses generic pharmaceutical products primarily in Europe through its third-party business; and provides products in women's health, gastroenterology, urology, and dermatology areas. The company sells its generic and brand pharmaceutical products primarily to drug wholesalers, retailers, and distributors, including national retail drug and food store chains, hospitals, clinics, mail order retailers, government agencies, and managed healthcare providers. It has a collaboration agreements with Amgen, Inc. to develop and commercialize biosimilar versions of Herceptin, Avastin, Rituxan/Mab Thera, and Erbitux; Ironwood Pharmaceuticals to develop and commercialize Linzessfor the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; Sanofi-Aventis U.S. LLC; and Trevena for the development of TRV027. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PYOTT DAVID E IChairman of the Board and CEOFeb 20Option Exercise0.001,3790166,379Feb 24 09:52 PM
Gangolli Julian SCVP & Pres, North AmericaFeb 20Option Exercise0.0051402,418Feb 24 09:44 PM